Sort
48,018 grants matching “immunotherapy”
Intrapleural immunotherapeutic nanoparticles for MPE treatment
$449,180Dawen Zhao · Wake Forest University Health Sciences · R01 · FY2022 · CA
Programming of CD8+ T Cell Tolerance by B Cell APC
$449,155Stephen Philip Schoenberger · La Jolla Institute For Immunology · R01 · FY2011 · AI
In Vitro Approach To Problems of Clinical Allergy
$449,138Johns Hopkins University · R01 · FY2001 · AI
The role of antigenic strength in the primary and memory responses of pathogen sp
$449,087K. Scott Weber · Brigham Young University · R15 · FY2013 · AI
Epitope-Specific Targeting of Tau Aggregates.
$449,080Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2016 · NS
Epitope-Specific Targeting of Tau Aggregates.
$449,080Einar M Sigurdsson · New York University School Of Medicine · R01 · FY2015 · NS
The role of chromosomal instability in tumor evolution
$449,000Samuel F Bakhoum · Sloan-Kettering Inst Can Research · DP5 · FY2022 · OD
The role of chromosomal instability in tumor evolution
$449,000Samuel F Bakhoum · Sloan-Kettering Inst Can Research · DP5 · FY2019 · OD
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
$449,000Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI
The role of chromosomal instability in tumor evolution
$449,000Samuel F Bakhoum · Sloan-Kettering Inst Can Research · DP5 · FY2018 · OD
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
$449,000Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2021 · AI
Characterizing the Mechanism of DPP8/9 Inhibitor-Induced Pyroptosis
$449,000Daniel Bachovchin · Sloan-Kettering Inst Can Research · R01 · FY2022 · AI
The role of chromosomal instability in tumor evolution
$449,000Samuel F Bakhoum · Sloan-Kettering Inst Can Research · DP5 · FY2021 · OD
The role of chromosomal instability in tumor evolution
$449,000Samuel F Bakhoum · Sloan-Kettering Inst Can Research · DP5 · FY2020 · OD
DEVELOPMENT OF GENOMICS BASED PERSONALIZED CANCER IMMUNOTHERAPY
$448,985Robert David Schreiber · Washington University · R01 · FY2016 · CA
Novel mechanisms regulating PD-1 signaling and function
$448,861Adam Mor · Columbia University Health Sciences · R01 · FY2024 · AI
Metabolic checkpoint in dendritic cell subsets and adaptive immunity
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R37 · FY2019 · AI
Establishment, maintenance, and consequences of asymmetric cell division in T cells
$448,750Douglas R Green · St. Jude Children'S Research Hospital · R01 · FY2019 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2020 · AI
Hippo signaling in stable regulatory activity and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Metabolic checkpoint in dendritic cell subsets and adaptive immunity
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R37 · FY2023 · AI
Establishment, maintenance, and consequences of asymmetric cell division in T cells
$448,750Douglas R Green · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2021 · AI
Metabolic checkpoint in dendritic cell subsets and adaptive immunity
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R37 · FY2020 · AI
Nutrient sensing and lysosomal signaling in regulatory T cells and immune tolerance
$448,750Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2019 · AI